powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1992024434
Kaihong Mi
MD, PHD
Hematology-Oncology
Harrisburg,
PA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
1,354
Beneficiaries
—
Total drug cost
$2.6M
Distinct drugs
33
Brand share
30.4%
Top prescribed drugs
Apixaban
125 claims
Acyclovir
96 claims
Dexamethasone
87 claims
Ondansetron Hcl
85 claims
Prochlorperazine Maleate
83 claims
QUALITY · MIPS · 2024
Final MIPS score
87.9
Quality
78.3
Cost
75.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.54%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$190
Payment records
2
By payment type
Food and Beverage
$122
Education
$68
Top paying entities
Food and Beverage
$122
Education
$68
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
584
Unique beneficiaries
—
Total services
843
Distinct HCPCS
7
Medicare payment
$67K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 417 Hematology-Oncology providers in PA — above median (cohort median 753).
